Accéder au contenu
Merck

Immunosuppressive monocytes: possible homeostatic mechanism to restrain chronic intestinal inflammation.

Journal of leukocyte biology (2014-04-04)
Elvira Kurmaeva, Dhruva Bhattacharya, Wendy Goodman, Sara Omenetti, Amber Merendino, Seth Berney, Theresa Pizarro, Dmitry V Ostanin
RÉSUMÉ

Chronic colitis is accompanied by extensive myelopoiesis and accumulation of CD11b+Gr-1+ cells in spleens and secondary lymphoid tissues. Although cells with similar phenotype have been described in cancer, chronic infection, or autoimmunity, where they were associated with suppression of T cell responses, little is known regarding how these cells affect CD4 T cell responses in the context of chronic intestinal inflammation. Therefore, we undertook this study to characterize the interplay between colitis-induced myeloid cells and CD4 T cell. Within the CD11b+Gr-1+ population, only monocytes (Ly6G(neg)Ly6C(high)) but not other myeloid cell subsets suppressed proliferation and production of cytokines by CD4 T cells. Suppression was mediated by cell-contact, NO and partially by IFN-γ and PGs. Interestingly, Ly6C(high) MDCs, isolated from colitic colons, showed up-regulation of iNOS and arginase-1 and were more potent suppressors than those isolated from spleen. On a single-cell level, MDCs inhibited Th1 responses but enhanced generation of foxp3+ T cells. MDCs, cocultured with activated/Teffs, isolated from inflamed colons under hypoxic (1% O2) conditions typical for the inflamed intestine, suppressed proliferation but not their production of proinflammatory cytokines and chemokines. Taken together, expansion of monocytes and MDCs and activation of their suppressive properties may represent a homeostatic mechanism aimed at restraining excessive T cell activation during chronic inflammatory settings. The contribution of immunosuppressive monocytes/MDCs to chronic colitis and their role in shaping T cell responses in vivo require further investigation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Formaldéhyde solution, for molecular biology, 36.5-38% in H2O
SAFC
Formaldéhyde solution, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Formaldéhyde solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
SAFC
L-Arginine
Supelco
Formaldéhyde solution, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
Formaldéhyde solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Sigma-Aldrich
NG-Methyl-L-arginine acetate salt, ≥98% (TLC)
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
Sigma-Aldrich
Formaldéhyde solution, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
Formaldéhyde solution, tested according to Ph. Eur.
Sigma-Aldrich
L-Arginine, BioUltra, ≥99.5% (NT)
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Supelco
L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Indomethacin, European Pharmacopoeia (EP) Reference Standard